http://www.littlehedge.com/nearmap-introduction/ Taking advantage of recent price fall to enter with a buy rating. They also put out buy rating on NXT.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
